Drawing for ARENA PHARMACEUTICALS

USPTO serial 77089743

ARENA PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 3978374Status 710
Filing date
Status date
Registration date
Jun 14, 2011
Examiner
MIZELLE HOWARD, DEZMONA JULYE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ARENA PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

J. Allison Strickland

J. Allison Strickland Fross Zelnick Lehrman & Zissu, P.C.4 TIMES SQUARE, 17TH FLOORNew York, NY 10036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations and pharmaceutical compounds for the treatment of metabolic disorders, disorders of the central nervous system, cardiovascular disorders, and inflammatory and auto immunity disordersSECTION 8 - CANCELLED—
042scientific and technological services, namely, medical laboratories; scientific research, studies, and development for others in the field of pharmaceuticals; scientific research and development for others, namely, pharmaceutical discovery, pharmaceutical screening assay development and studies, structure activity relationship studies, process development relating to synthesis and scalability for active pharmaceutical ingredients, large scale synthesis of active pharmaceutical ingredients, and formulation development; conducting and evaluating clinical trialsSECTION 8 - CANCELLEDMay 14, 1998

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 19, 2018C8..CANCELLED SEC. 8 (6-YR)—
Apr 5, 2017CORVREVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED—
Jan 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 15, 2013CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 15, 2013COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 14, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 7, 2011SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
May 6, 2011REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
May 4, 2011CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Apr 11, 2011SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Apr 7, 2011IUAFUSE AMENDMENT FILED—
Apr 7, 2011EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 24, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 24, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 23, 2010EX5GSOU EXTENSION 5 GRANTED—
Sep 14, 2010EXT5SOU EXTENSION 5 FILED—
Sep 14, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 23, 2010EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 22, 2010EX4GSOU EXTENSION 4 GRANTED—
Mar 16, 2010EXT4SOU EXTENSION 4 FILED—
Mar 16, 2010EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 30, 2009EX3GSOU EXTENSION 3 GRANTED—
Sep 22, 2009EXT3SOU EXTENSION 3 FILED—
Sep 22, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 11, 2009EX2GSOU EXTENSION 2 GRANTED—
Mar 11, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 24, 2009EXT2SOU EXTENSION 2 FILED—
Feb 24, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 11, 2008EX1GSOU EXTENSION 1 GRANTED—
Sep 11, 2008EXT1SOU EXTENSION 1 FILED—
Sep 11, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 8, 2008NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 15, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 26, 2007NPUBNOTICE OF PUBLICATION—
Dec 11, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 11, 2007ALIEASSIGNED TO LIE—
Nov 5, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 3, 2007TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 2, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 2, 2007TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 14, 2007GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 14, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 12, 2007DOCKASSIGNED TO EXAMINER—
Jan 29, 2007NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance